APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Preformulation CDMO Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Preformulation CDMO Service Industry Growth and Trends Forecast to 2032

Report ID 17421988016 January 2026114 pages

Choose your research edition.

Industry ResearchPreformulation CDMO Service Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Preformulation CDMO Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Preformulation CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preformulation CDMO Service Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Preformulation CDMO Service Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

According to APO Research, the global Preformulation CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Preformulation CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Preformulation CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preformulation CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Preformulation CDMO Service market include Aenova, Ascendia Pharmaceutical, Aurigene Pharmaceutical Services, Corealis Pharma, CritiTech, Crystal Pharmatech, DPT Laboratories, Eirgen Pharma and Eurofins Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Preformulation CDMO Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Preformulation CDMO Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Preformulation CDMO Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Preformulation CDMO Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Preformulation CDMO Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Preformulation CDMO Service Market by Company

Aenova

Ascendia Pharmaceutical

Aurigene Pharmaceutical Services

Corealis Pharma

CritiTech

Crystal Pharmatech

DPT Laboratories

Eirgen Pharma

Eurofins Scientific

Koziatek Consulting

Lonza

Oakwood Labs

Quotient Sciences

Sofpromed

Upperton Pharma Solutions

American Pharmaceutical Review

Bluepharma

Preformulation CDMO Service Segment by Type

Basic Characteristics CDMO Service

Pre-formulation Research CDMO Service

Prototype Formulation Development CDMO Service

Preformulation CDMO Service Segment by Application

Innovative Drug Development

Improved New Drug Development

Generic and Biosimilar Drug Development

Others

Preformulation CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preformulation CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preformulation CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preformulation CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Preformulation CDMO Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Preformulation CDMO Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Preformulation CDMO Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Preformulation CDMO Service Market Share by Region (2021-2026) Table 4. Global Preformulation CDMO Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Preformulation CDMO Service Market Share by Region (2027-2032) Table 6. Global Preformulation CDMO Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Preformulation CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Preformulation CDMO Service Market Size Share by Type (2021-2026) Table 9. Global Preformulation CDMO Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Preformulation CDMO Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Preformulation CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Preformulation CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Preformulation CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Preformulation CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Preformulation CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Preformulation CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Preformulation CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Preformulation CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Preformulation CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Preformulation CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Preformulation CDMO Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Preformulation CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Preformulation CDMO Service Market Size Share by Application (2021-2026) Table 24. Global Preformulation CDMO Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Preformulation CDMO Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Preformulation CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Preformulation CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Preformulation CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Preformulation CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Preformulation CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Preformulation CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Preformulation CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Preformulation CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Preformulation CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Preformulation CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Preformulation CDMO Service Industry Trends Table 37. Preformulation CDMO Service Industry Drivers Table 38. Preformulation CDMO Service Industry Opportunities and Challenges Table 39. Preformulation CDMO Service Industry Restraints Table 40. Global Preformulation CDMO Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Preformulation CDMO Service Revenue Market Share by Company (2021-2026) Table 42. Global Preformulation CDMO Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Preformulation CDMO Service Key Company Headquarters & Area Served Table 44. Global Preformulation CDMO Service Company, Product Type & Application Table 45. Global Preformulation CDMO Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Preformulation CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Aenova Company Information Table 49. Aenova Business Overview Table 50. Aenova Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Aenova Preformulation CDMO Service Product Portfolio Table 52. Aenova Recent Development Table 53. Ascendia Pharmaceutical Company Information Table 54. Ascendia Pharmaceutical Business Overview Table 55. Ascendia Pharmaceutical Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Ascendia Pharmaceutical Preformulation CDMO Service Product Portfolio Table 57. Ascendia Pharmaceutical Recent Development Table 58. Aurigene Pharmaceutical Services Company Information Table 59. Aurigene Pharmaceutical Services Business Overview Table 60. Aurigene Pharmaceutical Services Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Aurigene Pharmaceutical Services Preformulation CDMO Service Product Portfolio Table 62. Aurigene Pharmaceutical Services Recent Development Table 63. Corealis Pharma Company Information Table 64. Corealis Pharma Business Overview Table 65. Corealis Pharma Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Corealis Pharma Preformulation CDMO Service Product Portfolio Table 67. Corealis Pharma Recent Development Table 68. CritiTech Company Information Table 69. CritiTech Business Overview Table 70. CritiTech Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. CritiTech Preformulation CDMO Service Product Portfolio Table 72. CritiTech Recent Development Table 73. Crystal Pharmatech Company Information Table 74. Crystal Pharmatech Business Overview Table 75. Crystal Pharmatech Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Crystal Pharmatech Preformulation CDMO Service Product Portfolio Table 77. Crystal Pharmatech Recent Development Table 78. DPT Laboratories Company Information Table 79. DPT Laboratories Business Overview Table 80. DPT Laboratories Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. DPT Laboratories Preformulation CDMO Service Product Portfolio Table 82. DPT Laboratories Recent Development Table 83. Eirgen Pharma Company Information Table 84. Eirgen Pharma Business Overview Table 85. Eirgen Pharma Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Eirgen Pharma Preformulation CDMO Service Product Portfolio Table 87. Eirgen Pharma Recent Development Table 88. Eurofins Scientific Company Information Table 89. Eurofins Scientific Business Overview Table 90. Eurofins Scientific Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Eurofins Scientific Preformulation CDMO Service Product Portfolio Table 92. Eurofins Scientific Recent Development Table 93. Koziatek Consulting Company Information Table 94. Koziatek Consulting Business Overview Table 95. Koziatek Consulting Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Koziatek Consulting Preformulation CDMO Service Product Portfolio Table 97. Koziatek Consulting Recent Development Table 98. Lonza Company Information Table 99. Lonza Business Overview Table 100. Lonza Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Lonza Preformulation CDMO Service Product Portfolio Table 102. Lonza Recent Development Table 103. Oakwood Labs Company Information Table 104. Oakwood Labs Business Overview Table 105. Oakwood Labs Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Oakwood Labs Preformulation CDMO Service Product Portfolio Table 107. Oakwood Labs Recent Development Table 108. Quotient Sciences Company Information Table 109. Quotient Sciences Business Overview Table 110. Quotient Sciences Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Quotient Sciences Preformulation CDMO Service Product Portfolio Table 112. Quotient Sciences Recent Development Table 113. Sofpromed Company Information Table 114. Sofpromed Business Overview Table 115. Sofpromed Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Sofpromed Preformulation CDMO Service Product Portfolio Table 117. Sofpromed Recent Development Table 118. Upperton Pharma Solutions Company Information Table 119. Upperton Pharma Solutions Business Overview Table 120. Upperton Pharma Solutions Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Upperton Pharma Solutions Preformulation CDMO Service Product Portfolio Table 122. Upperton Pharma Solutions Recent Development Table 123. American Pharmaceutical Review Company Information Table 124. American Pharmaceutical Review Business Overview Table 125. American Pharmaceutical Review Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. American Pharmaceutical Review Preformulation CDMO Service Product Portfolio Table 127. American Pharmaceutical Review Recent Development Table 128. Bluepharma Company Information Table 129. Bluepharma Business Overview Table 130. Bluepharma Preformulation CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Bluepharma Preformulation CDMO Service Product Portfolio Table 132. Bluepharma Recent Development Table 133. North America Preformulation CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Preformulation CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Preformulation CDMO Service Market Share by Country (2021-2026) Table 136. North America Preformulation CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Preformulation CDMO Service Market Share Forecast by Country (2027-2032) Table 138. Europe Preformulation CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Preformulation CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Preformulation CDMO Service Market Share by Country (2021-2026) Table 141. Europe Preformulation CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Preformulation CDMO Service Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Preformulation CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Preformulation CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Preformulation CDMO Service Market Share by Country (2021-2026) Table 146. Asia-Pacific Preformulation CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Preformulation CDMO Service Market Share Forecast by Country (2027-2032) Table 148. Latin America Preformulation CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Preformulation CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Preformulation CDMO Service Market Share by Country (2021-2026) Table 151. Latin America Preformulation CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Preformulation CDMO Service Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Preformulation CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Preformulation CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Preformulation CDMO Service Market Share by Country (2021-2026) Table 156. Middle East & Africa Preformulation CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Preformulation CDMO Service Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Preformulation CDMO Service Product Image Figure 3. Global Preformulation CDMO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Preformulation CDMO Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Preformulation CDMO Service Market Share by Region: 2025 VS 2032 Figure 6. Global Preformulation CDMO Service Market Share by Region (2021-2032) Figure 7. North America Preformulation CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Preformulation CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Preformulation CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Preformulation CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Preformulation CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Basic Characteristics CDMO Service Image Figure 13. Global Basic Characteristics CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Pre-formulation Research CDMO Service Image Figure 15. Global Pre-formulation Research CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Prototype Formulation Development CDMO Service Image Figure 17. Global Prototype Formulation Development CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Preformulation CDMO Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Preformulation CDMO Service Market Share by Type 2025 VS 2032 Figure 20. North America Preformulation CDMO Service Market Size Share by Type (2021-2032) Figure 21. Europe Preformulation CDMO Service Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Preformulation CDMO Service Market Size Share by Type (2021-2032) Figure 23. Latin America Preformulation CDMO Service Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Preformulation CDMO Service Market Size Share by Type (2021-2032) Figure 25. Innovative Drug Development Image Figure 26. Global Innovative Drug Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Improved New Drug Development Image Figure 28. Global Improved New Drug Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Generic and Biosimilar Drug Development Image Figure 30. Global Generic and Biosimilar Drug Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Preformulation CDMO Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Preformulation CDMO Service Market Share by Application 2025 VS 2032 Figure 35. North America Preformulation CDMO Service Market Size Share by Application (2021-2032) Figure 36. Europe Preformulation CDMO Service Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Preformulation CDMO Service Market Size Share by Application (2021-2032) Figure 38. Latin America Preformulation CDMO Service Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Preformulation CDMO Service Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Preformulation CDMO Service Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Preformulation CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Preformulation CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Preformulation CDMO Service Market Share by Country (2021-2032) Figure 45. Europe Preformulation CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Preformulation CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Preformulation CDMO Service Market Share by Country (2021-2032) Figure 48. Asia-Pacific Preformulation CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Preformulation CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Preformulation CDMO Service Market Share by Country (2021-2032) Figure 51. Latin America Preformulation CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Preformulation CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Preformulation CDMO Service Market Share by Country (2021-2032) Figure 54. Middle East & Africa Preformulation CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Preformulation CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Preformulation CDMO Service Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Basic Characteristics CDMO Service
  • Pre-formulation Research CDMO Service
  • Prototype Formulation Development CDMO Service
Applications
  • Innovative Drug Development
  • Improved New Drug Development
  • Generic and Biosimilar Drug Development
  • Others
Companies covered
  • Aenova
  • Ascendia Pharmaceutical
  • Aurigene Pharmaceutical Services
  • Corealis Pharma
  • CritiTech
  • Crystal Pharmatech
  • DPT Laboratories
  • Eirgen Pharma
  • Eurofins Scientific
  • Koziatek Consulting
  • Lonza
  • Oakwood Labs
  • Quotient Sciences
  • Sofpromed
  • Upperton Pharma Solutions
  • American Pharmaceutical Review
  • Bluepharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Preformulation CDMO Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Preformulation CDMO Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Preformulation CDMO Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Preformulation CDMO Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Preformulation CDMO Service Market Size (2021-2032)
  8. 1.5.1 North America Preformulation CDMO Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Preformulation CDMO Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Preformulation CDMO Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Preformulation CDMO Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Preformulation CDMO Service Market Size Growth Rate (2021-2032)
2 Preformulation CDMO Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Basic Characteristics CDMO Service
  3. 2.1.2 Pre-formulation Research CDMO Service
  4. 2.1.3 Prototype Formulation Development CDMO Service
  5. 2.2 Global Preformulation CDMO Service Market Size by Type
  6. 2.2.1 Global Preformulation CDMO Service Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Preformulation CDMO Service Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Preformulation CDMO Service Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Preformulation CDMO Service Market Size by Regions
  10. 2.3.1 North America Preformulation CDMO Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Preformulation CDMO Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Preformulation CDMO Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Preformulation CDMO Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Preformulation CDMO Service Market Size Breakdown by Type (2021-2026)
3 Preformulation CDMO Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Innovative Drug Development
  3. 3.1.2 Improved New Drug Development
  4. 3.1.3 Generic and Biosimilar Drug Development
  5. 3.1.4 Others
  6. 3.2 Global Preformulation CDMO Service Market Size by Application
  7. 3.2.1 Global Preformulation CDMO Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Preformulation CDMO Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Preformulation CDMO Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Preformulation CDMO Service Market Size by Regions
  11. 3.3.1 North America Preformulation CDMO Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Preformulation CDMO Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Preformulation CDMO Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Preformulation CDMO Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Preformulation CDMO Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Preformulation CDMO Service Industry Trends
  2. 4.2 Preformulation CDMO Service Industry Drivers
  3. 4.3 Preformulation CDMO Service Industry Opportunities and Challenges
  4. 4.4 Preformulation CDMO Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Preformulation CDMO Service Revenue (2021-2026)
  2. 5.2 Global Preformulation CDMO Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Preformulation CDMO Service Key Company Headquarters & Area Served
  4. 5.4 Global Preformulation CDMO Service Company, Product Type & Application
  5. 5.5 Global Preformulation CDMO Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Preformulation CDMO Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Preformulation CDMO Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Preformulation CDMO Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Aenova
  2. 6.1.1 Aenova Company Information
  3. 6.1.2 Aenova Business Overview
  4. 6.1.3 Aenova Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Aenova Preformulation CDMO Service Product Portfolio
  6. 6.1.5 Aenova Recent Developments
  7. 6.2 Ascendia Pharmaceutical
  8. 6.2.1 Ascendia Pharmaceutical Company Information
  9. 6.2.2 Ascendia Pharmaceutical Business Overview
  10. 6.2.3 Ascendia Pharmaceutical Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Ascendia Pharmaceutical Preformulation CDMO Service Product Portfolio
  12. 6.2.5 Ascendia Pharmaceutical Recent Developments
  13. 6.3 Aurigene Pharmaceutical Services
  14. 6.3.1 Aurigene Pharmaceutical Services Company Information
  15. 6.3.2 Aurigene Pharmaceutical Services Business Overview
  16. 6.3.3 Aurigene Pharmaceutical Services Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Aurigene Pharmaceutical Services Preformulation CDMO Service Product Portfolio
  18. 6.3.5 Aurigene Pharmaceutical Services Recent Developments
  19. 6.4 Corealis Pharma
  20. 6.4.1 Corealis Pharma Company Information
  21. 6.4.2 Corealis Pharma Business Overview
  22. 6.4.3 Corealis Pharma Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Corealis Pharma Preformulation CDMO Service Product Portfolio
  24. 6.4.5 Corealis Pharma Recent Developments
  25. 6.5 CritiTech
  26. 6.5.1 CritiTech Company Information
  27. 6.5.2 CritiTech Business Overview
  28. 6.5.3 CritiTech Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 CritiTech Preformulation CDMO Service Product Portfolio
  30. 6.5.5 CritiTech Recent Developments
  31. 6.6 Crystal Pharmatech
  32. 6.6.1 Crystal Pharmatech Company Information
  33. 6.6.2 Crystal Pharmatech Business Overview
  34. 6.6.3 Crystal Pharmatech Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Crystal Pharmatech Preformulation CDMO Service Product Portfolio
  36. 6.6.5 Crystal Pharmatech Recent Developments
  37. 6.7 DPT Laboratories
  38. 6.7.1 DPT Laboratories Company Information
  39. 6.7.2 DPT Laboratories Business Overview
  40. 6.7.3 DPT Laboratories Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 DPT Laboratories Preformulation CDMO Service Product Portfolio
  42. 6.7.5 DPT Laboratories Recent Developments
  43. 6.8 Eirgen Pharma
  44. 6.8.1 Eirgen Pharma Company Information
  45. 6.8.2 Eirgen Pharma Business Overview
  46. 6.8.3 Eirgen Pharma Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Eirgen Pharma Preformulation CDMO Service Product Portfolio
  48. 6.8.5 Eirgen Pharma Recent Developments
  49. 6.9 Eurofins Scientific
  50. 6.9.1 Eurofins Scientific Company Information
  51. 6.9.2 Eurofins Scientific Business Overview
  52. 6.9.3 Eurofins Scientific Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Eurofins Scientific Preformulation CDMO Service Product Portfolio
  54. 6.9.5 Eurofins Scientific Recent Developments
  55. 6.10 Koziatek Consulting
  56. 6.10.1 Koziatek Consulting Company Information
  57. 6.10.2 Koziatek Consulting Business Overview
  58. 6.10.3 Koziatek Consulting Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Koziatek Consulting Preformulation CDMO Service Product Portfolio
  60. 6.10.5 Koziatek Consulting Recent Developments
  61. 6.11 Lonza
  62. 6.11.1 Lonza Company Information
  63. 6.11.2 Lonza Business Overview
  64. 6.11.3 Lonza Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Lonza Preformulation CDMO Service Product Portfolio
  66. 6.11.5 Lonza Recent Developments
  67. 6.12 Oakwood Labs
  68. 6.12.1 Oakwood Labs Company Information
  69. 6.12.2 Oakwood Labs Business Overview
  70. 6.12.3 Oakwood Labs Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Oakwood Labs Preformulation CDMO Service Product Portfolio
  72. 6.12.5 Oakwood Labs Recent Developments
  73. 6.13 Quotient Sciences
  74. 6.13.1 Quotient Sciences Company Information
  75. 6.13.2 Quotient Sciences Business Overview
  76. 6.13.3 Quotient Sciences Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Quotient Sciences Preformulation CDMO Service Product Portfolio
  78. 6.13.5 Quotient Sciences Recent Developments
  79. 6.14 Sofpromed
  80. 6.14.1 Sofpromed Company Information
  81. 6.14.2 Sofpromed Business Overview
  82. 6.14.3 Sofpromed Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Sofpromed Preformulation CDMO Service Product Portfolio
  84. 6.14.5 Sofpromed Recent Developments
  85. 6.15 Upperton Pharma Solutions
  86. 6.15.1 Upperton Pharma Solutions Company Information
  87. 6.15.2 Upperton Pharma Solutions Business Overview
  88. 6.15.3 Upperton Pharma Solutions Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Upperton Pharma Solutions Preformulation CDMO Service Product Portfolio
  90. 6.15.5 Upperton Pharma Solutions Recent Developments
  91. 6.16 American Pharmaceutical Review
  92. 6.16.1 American Pharmaceutical Review Company Information
  93. 6.16.2 American Pharmaceutical Review Business Overview
  94. 6.16.3 American Pharmaceutical Review Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 American Pharmaceutical Review Preformulation CDMO Service Product Portfolio
  96. 6.16.5 American Pharmaceutical Review Recent Developments
  97. 6.17 Bluepharma
  98. 6.17.1 Bluepharma Company Information
  99. 6.17.2 Bluepharma Business Overview
  100. 6.17.3 Bluepharma Preformulation CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Bluepharma Preformulation CDMO Service Product Portfolio
  102. 6.17.5 Bluepharma Recent Developments
7 North America
  1. 7.1 North America Preformulation CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Preformulation CDMO Service Market Size by Country (2021-2026)
  3. 7.3 North America Preformulation CDMO Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Preformulation CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Preformulation CDMO Service Market Size by Country (2021-2026)
  3. 8.3 Europe Preformulation CDMO Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Preformulation CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Preformulation CDMO Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Preformulation CDMO Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Preformulation CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Preformulation CDMO Service Market Size by Country (2021-2026)
  3. 10.3 South America Preformulation CDMO Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Preformulation CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Preformulation CDMO Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Preformulation CDMO Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst